Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
XPeng is holding near the lows that followed JP Morgan's late-September downgrade, with the stock at $9.58, and the story this week is one of tentative stabilisation against a backdrop that still looks structurally challenged.
The borrow market has loosened since the seizure that accompanied JP Morgan's target cut, but conditions remain tight by any normal measure. Availability has recovered to roughly 21% from a low of under 7% in the days immediately following the downgrade, meaning for every five shares already borrowed, roughly one more can be sourced. That is an improvement, but the 52-week low was 0.27%, and the lending pool has repeatedly snapped shut under pressure this year. Cost to borrow has also pulled back, down about 21% on the week to 1.52%, after touching 3% in late September during the most acute phase of the squeeze. Short interest itself has edged slightly lower over the past day but is up roughly 0.9% on the week, sitting near 47 million shares. The ORTEX short score of 67.2 ranks in just the 8th percentile of the universe, reflecting how persistently elevated short positioning has been.
Options positioning has moved sharply against the recent trend, and that is the most interesting development this week. The put/call ratio has jumped to 0.36, more than two standard deviations above its 20-day average of 0.30, the highest defensive tilt in at least six months. Just a week ago the ratio was at its 52-week low of 0.27. The speed of the reversal suggests traders who were leaning long through call positioning have quickly shifted toward hedging, even as the stock itself has barely moved, up 0.2% on the week.
The Street remains predominantly bearish, and the JP Morgan downgrade ten days ago crystallised the direction of travel. Nick Lai moved from Overweight to Neutral with a target of $11.50, less than half his prior $24.00. Barclays has held Underweight through successive cuts and now sits at $14.00. The mean price target across the consensus is flagged in the data at a level that looks inconsistent with the stock's current price and recent analyst actions, likely reflecting stale or mixed-currency inputs, so that aggregate figure is omitted here. What is clear directionally is that the two most active voices on the name have been cutting, not raising. Factor scores reinforce the caution: EPS momentum ranks in the bottom 1st and 2nd percentile over 30 and 90 days respectively, while the EPS surprise score is an outlier at the 97th percentile, suggesting the company has beaten low expectations but cannot sustain upward revisions. EV/EBITDA has contracted over the past week, down roughly 1.5 turns, consistent with a market that is not re-rating the stock higher.
Retail attention, measured by Wikipedia page views, jumped to a z-score of 3.1 relative to the prior 90 days as of late September. This is an attention signal, not a revenue indicator, and the dataset carries no measured lead to XPeng's financials. But attention spikes of this magnitude have historically coincided with volatility events, and the timing lines up with the JP Morgan move rather than any fundamental development.
Peer Chinese EVs are outperforming this week. NIO is up 3.2% on the week and LI is roughly flat, with XPeng barely changed. Earnings history adds one further note of caution: the last two quarterly prints both produced negative one-day and five-day reactions, with the five-day move averaging around minus 6%. The next print is pencilled in for November 24, 47 days away.
With borrow availability still compressed by historical standards, options hedging at a multi-month high, and the stock sitting below even the most recently downgraded price target, the setup into November earnings is less about whether sentiment can recover and more about whether any operational data between now and the print gives the market a reason to revisit the bearish consensus.
See the live data behind this article on ORTEX.
Open XPEV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
